Arthritis News - 2000
December
- Hip Protectors Reduce the Risk of Hip Fracture 12/27/00
- Etanercept and Infliximab Prove Effective in Slowing Joint Damage Caused by Rheumatoid Arthritis 12/14/00
November
- Attention! Important Information for Patients Currently Receiving Enbrel® Therapy 11/22/00
- Rheumatologists Enhance Quality of Care for Patients with Rheumatoid Arthritis 11/13/00
October
- Celecoxib (Celebrex®) Long-Term Safety Study 10/27/00
- Post-Marketing Reports of Rare Adverse Events in Patients Receiving Etanercept 10/16/00
- Increased Risk of Subsequent Osteoarthritis in Individuals with Previous Joint Injury 10/13/00
- FDA Approves Sulfasalazinein Treatment of Juvenile Rheumatoid Arthritis 10/3/00
September
- Sex-related Survival Differences in Heart Failure May be Related to Differences in TNF-receptor Expression 9/19/00
- Marital Satisfaction in Couples with Rheumatoid Arthritis 9/5/00
August
- NF-kb and C-Rel Transcription Factors Have Distinct Roles in Inflammatory Arthritis 8/18/00
- Etanercept Shown to be Safe and Efficacious for the Treatment of Psoriatic Arthritis and Psoriasis 8/9/00
July
- Effect of Rofecoxib on Renal function is Similar to Nonselective NSAIDs 7/28/00
- Celecoxib Reduces the Number of Colorectal Polyps 7/19/00
- Hopkins Ranks #1 in US News & World Report 7/7/00
- Effect of Rofecoxib on Renal function is Similar to Nonselective NSAIDs 7/28/00
June
- Interleukin-18 Acts as a Proinflammatory Stimulus in Rheumatoid Arthritis 6/26/00
- FDA Approves Entanercept for First-Line Treatment for Rheumatoid Arthritis 6/15/00
- A Pilot Study of Workplace Challenges and Adaptations Made by Rheumatoid Arthritis Patients 6/5/00
May
- Meloxicam (Mobic) Recieves FDA Approval 5/24/00
- A Possible Mechanism for Feedback Control in Joint Inflamation 5/17/00
- The Use of Hip and Knee
Replacement is Lower in Women Compared to Men 5/8/00
April
- Risedronate (Actonel) Receives FDA Approval For the Treatment and Prevention of Osteoporosis 4/21/00
- FDA Recommends Use of Etanercept to Delay Radiographic Progression of Joint Damage in Patients with Early Rheumatoid Arthritis 4/13/00
- Meta-Analysis Shown No Association Between Breast Implants and Connective-Tissue Disease 4/10/00
March
- Safety Updates to the Arava Labeling 3/31/00
- Efficacy of Etanercept Shown in Juvenile Rheumatoid Arthritis 3/27/00
- New FDA Approved Labeling for Sodium Hyaluronate (Hyalgan) 3/21/00
- Celecoxib (Celebrex) Receives FDA Approval as Adjunctive Treatment for FAP 3/21/00
- Methotrexate May Decrease Rate of Mortality in Rheumatoid Arthritis (RA) 3/3/00
February
*Arthritis news summaries and editorials are written by Jon Giles, M.D., Joan Bathon, M.D., and Clifton O. Bingham, M.D. unless otherwise noted.